#Prolacta_Bioscience
Japan Approves Prolacta Bioscience's Human Milk-Based Supplements as Prescription Medicine#Japan#Tokyo#neonatal_care#Prolacta_Bioscience#PreemieFort
Japan Approves Prolacta Bioscience's Human Milk-Based Supplements as Prescription Medicine
In a groundbreaking development, Japan has approved Prolacta Bioscience’s human milk fortifiers as prescription medication for fragile infants facing significant health risks.
third-news.com
February 19, 2026 at 6:36 PM
Japan Makes History with Approval of Innovative Human Milk-Based Fortifiers for Infant Care#Japan#Tokyo#neonatal_care#Prolacta_Bioscience#PreemieFort
Japan Makes History with Approval of Innovative Human Milk-Based Fortifiers for Infant Care
Japan's Ministry of Health has approved Prolacta Bioscience's human milk-based fortifiers as prescription drugs for vulnerable infants, revolutionizing neonatal care.
third-news.com
February 18, 2026 at 2:58 PM
Celebrating 20 Years of Advancements in NICU Nutrition for Premature Infants#United_States#Prolacta_Bioscience#Duarte#NICU#PreemieFortifiers
Celebrating 20 Years of Advancements in NICU Nutrition for Premature Infants
Prolacta Bioscience marks two decades of innovation in NICU nutrition, providing 100% human milk-based products for babies under 3 pounds.
third-news.com
September 2, 2026 at 1:30 PM
Japan Approves Prolacta Bioscience's Human Milk-Based Fortifiers as Prescription Medication#Japan#Prolacta_Bioscience#Duarte#Human_Milk#PreemieFort
Japan Approves Prolacta Bioscience's Human Milk-Based Fortifiers as Prescription Medication
Prolacta Bioscience has announced that Japan has officially approved its 100% human milk-based fortifiers, marking a new era in neonatal care for vulnerable infants in the NICU.
third-news.com
February 19, 2026 at 8:29 AM
Exclusive Human Milk Diet Significantly Reduces NEC Risk in Premature Infants: In-Depth Analysis#United_States#Prolacta_Bioscience#Duarte#Human_Milk#NEC
Exclusive Human Milk Diet Significantly Reduces NEC Risk in Premature Infants: In-Depth Analysis
A recent comprehensive meta-analysis reveals that an Exclusive Human Milk Diet can lower the risk of necrotizing enterocolitis in premature infants by nearly 49%.
third-news.com
November 12, 2025 at 2:50 PM
Prolacta Bioscience Celebrates Nearly 20 Years of Advancements in Infant Nutrition for Premature Babies#USA#Prolacta_Bioscience#Duarte#Human_Milk-Based_Products#Neonatal_Nutrition
Prolacta Bioscience Celebrates Nearly 20 Years of Advancements in Infant Nutrition for Premature Babies
Prolacta Bioscience is renowned for its innovative 100% human milk-based nutritional solutions for critically ill infants, marking two decades of excellence.
third-news.com
October 14, 2025 at 2:13 PM
Prolacta Bioscience Celebrates Significant NICU Milestone of 125,000 Supported Preemies#United_States#Prolacta_Bioscience#Duarte#NICU#preemies
Prolacta Bioscience Celebrates Significant NICU Milestone of 125,000 Supported Preemies
Prolacta Bioscience marks a major milestone during NICU Awareness Month, aiding over 125,000 premature infants with its unique breast milk formulas.
third-news.com
September 9, 2025 at 2:02 PM